DR Rodney Luwor

DR Rodney Luwor


  • Biochemistry and cell biology (Cancer, Cell signalling, cancer therapeutics)



  • Dr Luwor has almost two decades experience in using human cancer models and human patient samples to investigate the genetic and molecular alterations associated with cancer. Further to this Dr Luwor has expertise in developing molecular therapeutics for inhibition of tumour growth and progression. In particular, Dr Luwor has performed pre-clinical, therapeutic evaluation of several agents designed to block tumour growth. More recently, Dr Luwor has expanded his research interests to explore tumour resistance to both molecular targeted therapy and standard chemotherapy.   


Member of

  • The European Association for Cancer Research. Member 2011 -
  • The American Association for the Advancement of Science. Member 2008 -


Selected publications


Investigator on

Additional Grant Information

  • 2007 Early Career Researcher Grant funded by the University of Melbourne ($38,526). Title: Growth Factor Mediated Suppression of TGF-b Signalling Enhances Tumour Development. 2007 Brain Tumour Research Fellowship funded by Cure for Life Foundation™ ($40,000). Title: Growth Factor Mediated Suppression of TGF-b Signalling Enhances Brain Tumour Development. 2009 - 2011 Winter & Glover Fellowship in Cancer Research funded by the Faculty of Medicine, Dentistry and Health Sciences; The University of Melbourne ($245,000) Title: Real-Time in vivo analysis of EGFR and TGF-beta therapeutics using Bioluminescent Imaging. 2012 Rebecca L Cooper Research Foundation - Treatment of brain tumours utilizing the Nanosponge Delivery System;. Stylli, S.S., Kaye, A.H., and Luwor, R.B. ($22,000). 2012-13 (0.5 FTE) Melbourne Brain Centre Research Fellowship (Salary: 0.5 FTE). 2013 Melbourne Health Grant-in-Aid. An Integrated Genomic Analysis of Human Glioblastoma Multiforme subtypes; Stylli, S.S., Luwor, R.B., Liubinas, S. and Hovens, C.M. ($25,000). 2014 Melbourne Health Grant-in-Aid. Identifying Novel Prognostic Markers of Glioma Progression and Resistance to Temozolomide; Stylli, S.S., Luwor, R.B., Ng W. and Kaye, A.H. ($25,000). 2014 Perpetual's Charitable Trust - Evaluating Predictive Molecular Markers in Glioblastoma Multiforme; Luwor, R.B. ($52,250). 2015 - 2018 NHMRC Project Grant (APP1080498) Improving targeted therapy for colorectal cancer; Putoczki, T.L., Luwor, R.B., Gibbs, P. and Griffin, M. ($936,198.50). 2015 - 2016 Cure Brain Cancer Foundation; Circulating microRNA as a biomarker in brain cancer; Morokoff, A.M., Drummond, K., Luwor, R.B., ($200,000). 2016 - 2019 Victorian Cancer Agency Mid-career Research Fellowship (VCA-MCRF-15017); Overcoming Resistance to Epidermal Growth Factor Receptor Targeted Therapy; ($559,088). 2016 Therapeutics Technologies Research Initiative; Identifying Novel Inhibitors using an FDA-Approved Drug Screen on a Drosophila B   


Education and training

  • PhD, University of Melbourne 2003
  • BSc (Hons), University of Melbourne 1998

Awards and honors

  • Post-graduate Award (APA), Australian Government, 2003
  • Best Scientific Presentation Prize, Austin Biomedical Alliance, 2002
  • Australian Postgraduate Award, University of Melbourne, 1999



Available for supervision

  • Y